Modeling pegylated liposomal doxorubicin-induced hand-foot syndrome and intestinal mucositis in zebrafish

Pegylated liposomal doxorubicin (PLD) has been widely used to treat cancer. The adverse effects of PLD noted in clinical practice, especially hand-foot syndrome (HFS), are regarded as unique, and the management methods for them remain limited. This study was aimed at developing a feasible experiment...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yau-Hung, Lee, Ya-Ting, Wen, Chi-Chung, Chen, Yun-Chen, Chen, Yu-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4085292/
https://www.ncbi.nlm.nih.gov/pubmed/25061318
http://dx.doi.org/10.2147/OTT.S63785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4085292/
https://www.ncbi.nlm.nih.gov/pubmed/25061318
http://dx.doi.org/10.2147/OTT.S63785

Ejemplares similares